| Document |
Document Title |
|
WO/2020/085845A1 |
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent compound of the present disclosure may be comprised in a light-emitting...
|
|
WO/2020/086367A1 |
Provided are novel prodrugs of esuberaprost and pharmaceutical compositions thereof, as well as methods of making and methods of using these prodrugs.
|
|
WO/2020/084094A1 |
The present invention relates to a process for preparing a nitrated compound, comprising the step of reacting a compound (A) comprising at least one substituted or unsubstituted aromatic or heteroaromatic ring, wherein said heteroaromati...
|
|
WO/2020/083327A1 |
Disclosed in the present invention is an organic compound containing a spirobifluorene structure, having a structure as represented by chemical formula (1), wherein Ar1(Ar2)N-(S1)m- and -(S2)n-NAr3(Ar4) are different, and have symmetrica...
|
|
WO/2020/086732A1 |
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
|
|
WO/2020/081631A1 |
Disclosed is a process to produce a purified vapor comprising dialkyl- furan-2,5-dicarboxylate (DAFD). Furan-2,5-dicarboxylic acid (FDCA) and an alcohol in an esterification zone to generate a crude diester stream containing dialkyl fura...
|
|
WO/2020/081579A1 |
Provided herein are methods and reagents for increasing chemosensitivity to chemotherapy and immunotherapy in cancer patients. Methods of treating cancer are provided, comprising administering to a patient in need thereof an effective am...
|
|
WO/2020/080702A1 |
The present invention provides a novel compound and an organic light emitting diode using same.
|
|
WO/2020/080849A1 |
The present specification relates to a compound of chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2020/080799A1 |
The present invention provides a novel compound and an organic light emitting diode using same.
|
|
WO/2020/077437A1 |
II and III Provided herein are Topoisomerase II inhibitory compounds having the structure of Formulas II and III and compositions thereof for use in the treatment of cancer. In particular, the Topoisomerase II inhibitory compounds descri...
|
|
WO/2020/080714A1 |
The present specification relates to a compound and an organic light-emitting device comprising same.
|
|
WO/2020/075763A1 |
This compound is represented by formula (1) or (2) (in formula (1) or (2), at least one of R1-R8 is a deuterium atom).
|
|
WO/2020/075027A1 |
The present application relate to crystalline azide compound of formula (II) which is used as an intermediate for the preparation of halichondrin B analogues such as eribulin or pharmaceutically acceptable salts thereof. The present appl...
|
|
WO/2020/075964A1 |
The present invention provides a novel compound and an organic light emitting diode using same.
|
|
WO/2020/075783A1 |
This compound is represented by formula (1) (in formula (1), at least one of R1-R8 is a deuterium atom, and Ar2 is a monovalent group represented by formula (2), (3), or (4)).
|
|
WO/2020/076100A1 |
The present invention relates to a novel Usnic acid derivative exhibiting an inhibitory effect on TSLP secretion or pharmaceutically acceptable salts thereof, and a use thereof.
|
|
WO/2020/072377A1 |
The present disclosure relates to compounds of the general formula (I) and pharmaceutical compositions containing them. The compounds are suitable as modulators of hemoglobin and thus useful in treating disorders mediated by hemoglobin s...
|
|
WO/2020/064564A1 |
Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, and their uses as insecticides.
|
|
WO/2020/067901A1 |
The invention is directed to a method for the preparation, in particular for the purification of 2,5-furandicarboxylic acid or a salt thereof, comprising crystallization of a 2,5-furandicarboxylic acid mono salt and then crystallizing 2,...
|
|
WO/2020/065492A1 |
A compound is represented by the following general formula (I): (I) wherein each of Rf1 and Rf2 is, independently, F, CF3, C2F5, C3F7, or C4F9, with the proviso that if either of Rf1 and Rf2 is fluorine, then the other is not fluorine; R...
|
|
WO/2020/065642A1 |
The present invention provides new GABAA receptor-binding compounds that modify the activation of GABAA, their use in in the preparation of a neuroactive pharmaceutical composition, improving sperm motility and labeling of biomolecules.
|
|
WO/2020/064641A1 |
The present invention refers to a method of producing furfural and optionally further basic chemicals from biomass material comprising treatment of the biomass material at elevated pressures and temperatures, to the condensates and solid...
|
|
WO/2020/065119A1 |
The invention relates to a group of compounds with a structural nucleus of acylhydrazone, which are capable of modulating the interaction between the proteins NCS-1 and Ric8a involved in the process of regulating the number of synapses a...
|
|
WO/2020/060011A1 |
The present invention relates to a method for preparing citalopram and escitalopram, and addition salts using same. In the preparation of citalopram and escitalopram, intermediate compounds are not separately obtained before a cyclizatio...
|
|
WO/2020/058160A1 |
The present invention relates to methods for controlling or preventing infestation of cereal plants by the phytopathogenic microorganism Fusarium pseudograminearum, comprising applying to a crop of plants, the locus thereof, or seed ther...
|
|
WO/2020/056553A1 |
The invention belongs to the field of organic chemistry, and particularly relates to a method for preparing a heterocyclic compound represented by formula I and salts thereof. Compared with the prior art, the invention avoids the use of ...
|
|
WO/2020/055177A1 |
The present invention provides a novel compound, a coating composition comprising same, and an organic light emitting diode using same.
|
|
WO/2020/054226A1 |
A thermal base generator is represented by formula (N1). This photosensitive resin composition contains the thermal base generator and a precursor of a heterocycle-containing polymer. In formula (N1), RN1 and RN2 each independently repre...
|
|
WO/2020/055725A1 |
Disclosed herein are novel methods of treating pain in a patient in need thereof by providing to the patient a selective dopamine D3 receptor antagonist/partial agonist which when used with an opioid analgesic, can mitigate the developme...
|
|
WO/2020/050339A1 |
Provided is an industrially useful method for manufacturing (1R,2S)-2-{[((2,4-dimethylpyrimidine-5-yl)oxy}methyl]-2-(3-f
luorophenyl)-N-(5-fluoropyridine-2-yl)cyclopropane-1-carboxa
mide. In the present invention, (1R,2S)-2-{[((2,4-dimet...
|
|
WO/2020/050663A1 |
The present invention relates to a method for chemical production of 3,6-anhydro-L-galactitol (L-AHGol), which is a novel sugar alcohol, and agarobititol (ABol), which is a disaccharide having the same agarobititol as a reductant end the...
|
|
WO/2020/050215A1 |
Provided for the purpose of efficient oxide production is a method for producing an oxide by oxidation of a starting compound in the presence of oxygen, characterized in that the starting compound is oxidized in the presence of manganese...
|
|
WO/2020/051207A2 |
The disclosure relates to aryl hydrocarbon receptor antagonists as well as methods of modulating aryl hydrocarbon receptor activity and expanding hematopoietic stem cells by culturing hematopoietic stem or progenitor cells in the presenc...
|
|
WO/2020/050368A1 |
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...
|
|
WO/2020/044245A1 |
The invention relates to a novel furan-containing sesquiterpene with the structure shown in Formula (X). (X) It can be obtained from the bark of the Melicope latifolia tree in relatively high concentration and has been found to have anti...
|
|
WO/2020/044771A1 |
Provided is an actinic-ray-sensitive or radiation-sensitive resin composition from which a pattern having excellent LWR performance can be produced. Also provided are a resist film, a pattern formation method and an electronic device man...
|
|
WO/2020/046362A1 |
Disclosed is a process to produce a purified vapor comprising dialkyl- furan-2,5-dicarboxylate (DAFD). Furan-2,5-dicarboxylic acid (FDCA) and an alcohol in an esterification zone to generate a crude diester stream containing dialkyi fura...
|
|
WO/2020/044213A1 |
The present invention provides compounds of formula (I) and formula (II): or a pharmaceutically acceptable salt or a stereoisomer thereof; wherein, ring A and ring B have the meanings given in the specification. The compounds of the pres...
|
|
WO/2020/046403A1 |
Disclosed is simple, novel, scalable and environment friendly process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts.
|
|
WO/2020/046124A1 |
The present invention is directed to the preparation of phthalic anhydride compounds and the intermediate phthalide compounds. In particular, the invention is directed to an improved bio-based route from furanic compounds to phthalic anh...
|
|
WO/2020/043639A1 |
The invention discloses a method for preparation of 1,4-sorbitan by dehydration of D-sorbitol, wherein one equivalent of water is removed and a cyclization occurs, followed by a treatment with ethanol and isopropanol.
|
|
WO/2020/043821A1 |
The present invention is directed to furan derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.
|
|
WO/2020/038592A1 |
A method for producing slcareolide comprising the following steps: (a) providing sclareol as starter material; (b) contacting the starter material sclareol with ozone in air or oxygen as the sole oxidant in an acidic medium.
|
|
WO/2020/034759A1 |
A liquid crystal composition having a negative dielectric constant, comprising liquid crystal compounds represented by general formulas I, II, and III. The general formula I is, the general formula II is, and the general formula III is. ...
|
|
WO/2020/034058A1 |
A process for the reductive amination of an α,β-unsaturated carbonyl compound and a process for the preparation of a tetrathydrofuran-derived amine starting from furfural or a derivative thereof.
|
|
WO/2020/034062A1 |
The invention relates to a process for the reductive amination of a carbonyl compound. The invention furthermore relates to a process for the preparation of a furan-derived amine starting from furfural or a derivative thereof.
|
|
WO/2020/036382A1 |
The present invention relates to a method for producing an intermediate useful for the synthesis of a diphenylmethane derivative that can be used as a SGLT inhibitor. A method for synthesizing a compound of formula 7 according to the pre...
|
|
WO/2020/031107A1 |
The invention is directed to substituted tetrahydrofuran derivatives. Specifically, the invention is directed to compounds according to Formula (I), wherein C, D, L1, L2, R1, R2, R3, R4, R5, R6, Y1, Y2, z1, z2, z3, z4, X1, X2, X3, X4, X5...
|
|
WO/2020/029846A1 |
Disclosed by the present invention is a rapid synthesis method for a biomass-based amine compound, comprising: by using formamide as an amine source, using formic acid as a hydrogen source, and using biomass aldehydes and ketones as raw ...
|
